UMIN ID: UMIN000056876
Registered date:30/01/2025
A multicenter retrospective study using 18F-FDG-PET/CT for the prediction of immunotherapy-related interstitial lung disease in lung cancer.
Basic Information
| Recruitment status | Pending |
|---|---|
| Health condition(s) or Problem(s) studied | Advanced or recurrent lung cancer |
| Date of first enrollment | 2025/02/01 |
| Target sample size | 200 |
| Countries of recruitment | Japan |
| Study type | Observational |
| Intervention(s) |
Outcome(s)
| Primary Outcome | Interstitial lung disease after administration of immune checkpoint inhibitors |
|---|---|
| Secondary Outcome | Onset of any adverse event after administration of immune checkpoint inhibitors Prognosis after administration of immune checkpoint inhibitors |
Key inclusion & exclusion criteria
| Age minimum | 18years-old |
|---|---|
| Age maximum | 100years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | (1) FDG uptake on lung region was difficult to evaluate owing to massive consolidation or pleural effusion (2) Patients with bilateral multiple primary lung cancers. |
Related Information
| Primary Sponsor | Niigata University Medical and Dental Hospital |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | None |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Satoshi Watanabe |
| Address | 1-754 Asahimachi-dori, Chuo-ku, Niigata City, Niigata Prefecture Japan 9518510 |
| Telephone | 025-368-9325 |
| satoshi7@med.niigata-u.ac.jp | |
| Affiliation | Niigata University Medical and Dental Hospital Department of Respiratory Medicine and Infectious Diseases |
| scientific contact | |
| Name | Satoshi Watanabe |
| Address | 1-754 Asahimachi-dori, Chuo-ku, Niigata City, Niigata Prefecture Japan |
| Telephone | 025-368-9325 |
| satoshi7@med.niigata-u.ac.jp | |
| Affiliation | Niigata University Medical and Dental Hospital Department of Respiratory Medicine and Infectious Diseases |